Healogics

Healogics, established in 1996, is a leading provider of advanced wound care services, operating across 49 locations. The company focuses on delivering specialized treatment for patients suffering from chronic wounds, including diabetic ulcers, surgical wounds, venous ulcers, pressure ulcers, trauma wounds, and arterial ulcers. With a dedicated team, Healogics aims to improve patient outcomes through evidence-based practices and innovative treatment modalities. Meet Healogics's team to understand the expertise driving their patient-centric approach.

The company's comprehensive service offering extends to outpatient wound care centers, emphasizing hyperbaric oxygen therapy and other advanced treatments. Healogics supports a significant patient base, employing between 1,000 and 5,000 professionals dedicated to wound healing. Their operational footprint spans numerous facilities, ensuring accessibility to specialized care for communities. The organization is committed to advancing the field of wound management through continuous learning and development for its staff.

Healogics generated a revenue of $436.5M. In May 2021, the company secured $165M in private equity funding from Marathon Asset Management, underscoring investor confidence in its market position and growth potential. The company operates within a competitive landscape, with key rivals including Curative and RestorixHealth, highlighting the dynamic nature of the healthcare services sector. For a deeper dive into their financial performance and strategic investments, Explore financial highlights.